Works by Xu, Xiaoyuan


Results: 96
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study.

    Published in:
    Infection & Drug Resistance, 2019, v. 12, p. 745, doi. 10.2147/IDR.S185120
    By:
    • Wu, Xiaoning;
    • Zhou, Jialing;
    • Xie, Wen;
    • Ding, Huiguo;
    • Ou, Xiaojuan;
    • Chen, Guofeng;
    • Ma, Anlin;
    • Xu, Xiaoyuan;
    • Ma, Hui;
    • Xu, Youqing;
    • Liu, Xiaoqing;
    • Meng, Tongtong;
    • Wang, Lin;
    • Sun, Yameng;
    • Wang, Bingqiong;
    • Kong, Yuanyuan;
    • Ma, Hong;
    • You, Hong;
    • Jia, Jidong
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Global multi-societies endorsement of the MAFLD definition.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 6, p. 1, doi. 10.1016/j.aohep.2024.101573
    By:
    • Alboraie, Mohamed;
    • Tawesak Tanwandee;
    • Xiaoyuan Xu;
    • Nikolova, Dafina;
    • Estupiñan, Enrique Carrera;
    • Ghazinyan, Hasmik;
    • Alawadhi, Sameer;
    • Ocama, Ponsiano;
    • Aghayeva, Gulnara;
    • Piscoya, Alejandro;
    • Farahat, Taghreed;
    • Prasad, Pramendra;
    • Lesmana, Cosmas Rinaldi Adithya;
    • Joshi, Shashank R.;
    • Al-Busafi, Said;
    • Milivojevic, Vladimir;
    • Kayamba, Violet;
    • Yeong Yeh Lee;
    • Alam, Shahinul;
    • Chengwei Tang
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50